OraSure Technologies Shares Outstanding 2010-2025 | OSUR

OraSure Technologies shares outstanding from 2010 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
OraSure Technologies Annual Shares Outstanding
(Millions of Shares)
2024 74
2023 74
2022 73
2021 72
2020 68
2019 62
2018 63
2017 61
2016 57
2015 57
2014 56
2013 56
2012 51
2011 47
2010 46
2009 46
OraSure Technologies Quarterly Shares Outstanding
(Millions of Shares)
2025-06-30 75
2025-03-31 75
2024-12-31 74
2024-09-30 75
2024-06-30 74
2024-03-31 74
2023-12-31 74
2023-09-30 74
2023-06-30 73
2023-03-31 74
2022-12-31 73
2022-09-30 73
2022-06-30 72
2022-03-31 72
2021-12-31 72
2021-09-30 72
2021-06-30 72
2021-03-31 73
2020-12-31 68
2020-09-30 73
2020-06-30 65
2020-03-31 62
2019-12-31 62
2019-09-30 62
2019-06-30 62
2019-03-31 62
2018-12-31 63
2018-09-30 63
2018-06-30 62
2018-03-31 61
2017-12-31 61
2017-09-30 62
2017-06-30 61
2017-03-31 59
2016-12-31 57
2016-09-30 57
2016-06-30 56
2016-03-31 56
2015-12-31 57
2015-09-30 57
2015-06-30 57
2015-03-31 57
2014-12-31 56
2014-09-30 57
2014-06-30 57
2014-03-31 56
2013-12-31 56
2013-09-30 56
2013-06-30 56
2013-03-31 55
2012-12-31 51
2012-09-30 54
2012-06-30 48
2012-03-31 48
2011-12-31 47
2011-09-30 47
2011-06-30 47
2011-03-31 47
2010-12-31 46
2010-09-30 47
2010-06-30 46
2010-03-31 46
2009-12-31 46
2009-09-30 46
2009-06-30 46
2009-03-31 46
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.212B $0.186B
OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $230.506B 27.03
Boston Scientific (BSX) United States $157.140B 37.47
Stryker (SYK) United States $149.815B 30.50
EssilorLuxottica (ESLOY) France $148.753B 0.00
Medtronic (MDT) Ireland $119.490B 16.86
Lonza Group Ag (LZAGY) Switzerland $50.052B 0.00
Haleon (HLN) United Kingdom $44.480B 25.41
ResMed (RMD) United States $42.323B 30.27
Agilent Technologies (A) United States $33.835B 22.06
GE HealthCare Technologies (GEHC) United States $33.726B 15.85
Terumo (TRUMY) Japan $27.731B 32.86
Koninklijke Philips (PHG) Netherlands $26.731B 17.68
Insulet (PODD) United States $23.441B 78.54
Zimmer Biomet Holdings (ZBH) United States $20.941B 13.33
Smith & Nephew SNATS (SNN) United Kingdom $16.385B 0.00
Baxter (BAX) United States $12.466B 9.63
Sunny Optical Technology (SNPTF) China $10.800B 0.00
Demant (WILYY) Denmark $8.121B 0.00
Bio-Rad Laboratories (BIO) United States $7.798B 28.64
Lantheus Holdings (LNTH) United States $3.817B 10.32
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.443B 24.09
Perrigo (PRGO) Ireland $3.255B 8.13
Prestige Consumer Healthcare (PBH) United States $3.201B 14.20
ICU Medical (ICUI) United States $3.045B 20.73
Haemonetics (HAE) United States $2.623B 11.71
LeMaitre Vascular (LMAT) United States $2.189B 46.95
AtriCure (ATRC) United States $1.793B 0.00
QuidelOrtho (QDEL) United States $1.789B 11.26
Curaleaf Holdings (CURLF) Canada $1.750B 0.00
Green Thumb Industries (GTBIF) United States $1.687B 72.46
AdaptHealth (AHCO) United States $1.262B 17.94
Phibro Animal Health (PAHC) United States $1.262B 16.14
Acuren (TIC) United States $1.220B 0.00
Neogen (NEOG) United States $1.210B 19.21
BioLife Solutions (BLFS) United States $1.196B 2496.00
Tilray Brands (TLRY) Canada $1.167B 0.00
Valneva SE (VALN) France $0.979B 0.00
InMode (INMD) Israel $0.897B 8.30
Kestra Medical Technologies (KMTS) United States $0.852B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.626B 0.00
SNDL (SNDL) Canada $0.581B 0.00
Verano Holdings (VRNOF) United States $0.557B 0.00
Cresco Labs (CRLBF) United States $0.535B 0.00
ZimVie (ZIMV) United States $0.535B 20.61
Surmodics (SRDX) United States $0.528B 0.00
Evolus (EOLS) United States $0.468B 0.00
VAREX IMAGING (VREX) United States $0.466B 16.04
CeriBell (CBLL) United States $0.425B 0.00
Owens & Minor (OMI) United States $0.412B 3.66
Sanuwave Health (SNWV) United States $0.338B 0.00
Capricor Therapeutics (CAPR) United States $0.328B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.317B 0.00
TerrAscend (TSNDF) Canada $0.303B 0.00
Canopy Growth (CGC) Canada $0.290B 0.00
Omeros (OMER) United States $0.285B 0.00
Brainsway (BWAY) Israel $0.279B 56.81
Sanara MedTech (SMTI) United States $0.274B 0.00
Aurora Cannabis (ACB) Canada $0.266B 0.00
Viemed Healthcare (VMD) United States $0.266B 20.18
High Tide (HITI) Canada $0.250B 0.00
Vireo Growth (VREOF) United States $0.238B 0.00
Quanterix (QTRX) United States $0.228B 0.00
Cerus (CERS) United States $0.222B 0.00
Exagen (XGN) United States $0.217B 0.00
Organigram Global (OGI) Canada $0.201B 0.00
TriSalus Life Sciences (TLSI) United States $0.194B 0.00
Utah Medical Products (UTMD) United States $0.185B 15.47
FitLife Brands (FTLF) United States $0.157B 19.34
Biote (BTMD) United States $0.147B 4.87
Jushi Holdings (JUSHF) United States $0.125B 0.00
Quipt Home Medical (QIPT) United States $0.098B 0.00
MacroGenics (MGNX) United States $0.094B 0.00
Fonar (FONR) United States $0.094B 12.10
Jin Medical (ZJYL) China $0.089B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.085B 0.00
Apyx Medical (APYX) United States $0.077B 0.00
Safety Shot (SHOT) United States $0.070B 0.00
Agape ATP (ATPC) $0.065B 0.00
Cytosorbents (CTSO) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.055B 31.80
Veru (VERU) United States $0.052B 0.00
Zynex (ZYXI) United States $0.047B 0.00
Nephros (NEPH) United States $0.043B 34.00
Modular Medical (MODD) United States $0.039B 0.00
United-Guardian (UG) United States $0.037B 14.21
Rockwell Medical (RMTI) United States $0.036B 0.00
Trinity Biotech (TRIB) Ireland $0.031B 0.00
Senestech (SNES) United States $0.023B 0.00
INLIF (INLF) $0.017B 0.00
Allurion Technologies (ALUR) United States $0.016B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
IM Cannabis (IMCC) Canada $0.012B 0.00
Flora Growth (FLGC) United States $0.012B 0.00
Cellectar Biosciences (CLRB) United States $0.008B 0.00
Innovative Eyewear (LUCY) United States $0.006B 0.00
Sharps Technology (STSS) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InterCure (INCR) Israel $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00